Records are supplied by study sponsors and investigators. A registry listing is not an endorsement or a guarantee of safety, availability or eligibility.
WCR feed checked: Nov 12, 2026.
Active, not recruitingNCT06742385
Crohn Disease · Ulcerative Colitis
Not applicable18 years - 80 yearsNeuilly-sur-Seine, France, France Telemonitoring is of definite theoretical interest for patients suffering from chronic diseases and could help to improve monitoring of treatment efficacy and tolerance, and hence remission and quality of life. Reimbursement is now planned in France …
By invitationNCT07212010
Cerebral Visual Impairment
Observational6 months - 72 monthsCincinnati, Ohio, United States Cerebral visual impairment (CVI) is one of the leading causes of pediatric visual impairment and negatively impacts the development of motor, language, and cognitive skills. This study proposes to (1) establish a novel and easy to use CVI screening a…
TerminatedNCT03792841
Metastatic Castration-resistant Prostate Cancer · Prostate Cancer
Phase 118 years - Not specifiedCampbell, California, United States +26 A phase 1 study evaluating the safety, tolerability, pharmacokinetics, and efficacy of prostate specific membrane antigen half-life extended bispecific T-cell engager acapatamab in subjects with metastatic castration-resistant prostate cancer, and to…
WithheldNCT06594575
Not reportedNot specified - Not specifiedLocation not listed Not yet recruitingNCT07777302
Otitis Media With Effusion (OME) · Eustachian Tube Dysfunction · Otitis Media With Effusion
Not applicable18 years - Not specifiedPittsburgh, Pennsylvania, United States This study evaluates the use of the EarFlo device in adults with clinically confirmed Eustachian tube dysfunction and/or otitis media with effusion. The purpose of the study is to assess the safety, tolerability, and short-term effects of device use …
RecruitingNCT05562466
Asthma
Phase 36 years - 11 yearsCABA, Buenos Aires, Argentina +58 The purpose of this study is to evaluate the superiority in terms of efficacy and evaluate the safety of QMF149 (indacaterol (acetate) / mometasone (furoate)) compared to budesonide in children from 6 to less than 12 years of age with asthma. * The s…
RecruitingNCT00483249
Thoracoabdominal Aortic Aneurysm · Paravisceral Abdominal Aortic Aneurysm
Not applicable18 years - Not specifiedSan Francisco, California, United States This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.
RecruitingNCT05714085
Heart Failure · Left Ventricular Systolic Dysfunction
Phase 2 / Phase 329 days - 17 yearsLos Angeles, California, United States +100 This study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline to Week 16 of the Base Period. The primary hypothesis is that vericiguat is superior to placebo in red…
Active, not recruitingNCT07436715
Fragility
Not applicable70 years - Not specifiedAlmería, ALMERÍA, Spain The aim of this quasi-experimental, pretest-posttest study with a post-intervention observational follow-up phase is to evaluate the effectiveness and medium-term sustainability of the Vivifrail multicomponent physical exercise program in improving f…
CompletedNCT03678233
Hypermetabolism in ICU · Loss of Muscle Mass · Functional Disability After ICU · ICU Acquired Hypogonadism · Treatment With Testosterone Gel in ICU
Phase 218 years - 79 yearsClermont-Ferrand, France Critically ill patients experience major insults that lead to increased protein catabolism. Hypermetabolism occurs early and rapidly during the first week of critical illness to provide amino acids for the production of energy via gluconeogenesis, an…
RecruitingNCT07428447
Essential Tremor, Movement Disorders · Essential Tremor · Essential Tremor-plus
Observational50 years - 85 yearsScottsdale, Arizona, United States +9 Background and Rationale Essential tremor (ET) affects over 6 million Americans and approximately 5% of adults over age 60. Patients with ET have a 10-20 times higher risk of developing Parkinson's disease (PD) compared to age-matched populations, wi…
Not yet recruitingNCT07929168
Multiple Trauma/Injuries · Wounds and Injuries
Observational18 years - Not specifiedCorbeil-Essonnes, France, France Background: Grade C trauma patients show no obvious severe injury at first assessment, but the mechanism or circumstances of the accident make serious lesions possible. Guidelines recommend a whole-body CT scan as first-line imaging1. The organizatio…
Retrieved from ClinicalTrials.gov: Nov 12, 2026. Overall study status may differ from a particular location’s status.
